Kerri Cavanaugh
Overview
Explore the profile of Kerri Cavanaugh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
912
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lopez A, Al Hussein Al Awamlh B, Huang L, Zhao Z, Koyama T, Hoffman K, et al.
Urol Oncol
. 2024 Dec;
43(4):271.e19-271.e28.
PMID: 39690079
Objectives: Compare functional outcomes and treatment-related regret over 10 years in Spanish- and English-speaking Hispanic men compared to non-Hispanic men following treatment of localized prostate cancer. Methods And Materials: Data...
2.
Campbell K, Posner A, Chen N, Cavanaugh K, Bhushan K, Janeway K, et al.
Pediatr Blood Cancer
. 2023 Sep;
70(12):e30681.
PMID: 37715723
Purpose: Phase 1 study assessing the safety and toxicity of cabozantinib in combination with topotecan and cyclophosphamide for relapsed osteosarcoma and Ewing sarcoma. Methods: Oral cabozantinib (25 mg/m ) was...
3.
Wadhwa A, Fried L, Cavanaugh K, MacKichan K, Sinha A, Adam S, et al.
Fed Pract
. 2023 May;
40(4):116-122b.
PMID: 37223661
Background: Home dialysis utilization is lower among veterans than in the general US population. Several sociodemographic factors and comorbidities contribute to peritoneal dialysis (PD) underutilization. In 2019, the Veterans Health...
4.
Golestaneh L, Karaboyas A, Cavanaugh K, Umeukeje E, Johns T, Thorpe Jr R, et al.
Kidney Int Rep
. 2021 Feb;
6(2):357-365.
PMID: 33615061
Introduction: Black men are over-represented in the end stage kidney disease population and are at disproportionate risk of unfavorable outcomes. There is a paucity of investigation to elucidate the mediators...
5.
Ozanne E, Noseworthy P, Cameron K, Schmidt M, Cavanaugh K, Pershing M, et al.
MDM Policy Pract
. 2020 Dec;
5(2):2381468320976364.
PMID: 33344769
No abstract available.
6.
Sperati C, Soman S, Agrawal V, Liu Y, Abdel-Kader K, Diamantidis C, et al.
PLoS One
. 2019 Aug;
14(8):e0221325.
PMID: 31437198
Background: Given the high prevalence of chronic kidney disease (CKD), primary care physicians (PCPs) frequently manage early stage CKD. Nonetheless, there are challenges in providing optimal CKD care in the...
7.
Greer R, Liu Y, Cavanaugh K, Diamantidis C, Estrella M, Sperati C, et al.
J Gen Intern Med
. 2019 Apr;
34(7):1228-1235.
PMID: 30993634
Background: Effective co-management of patients with chronic kidney disease (CKD) between primary care physicians (PCPs) and nephrologists is increasingly recognized as a key strategy to ensure the delivery of efficient...
8.
Umeukeje E, Young B, Fullerton S, Cavanaugh K, Owens D, Wilson J, et al.
J Am Soc Nephrol
. 2019 Mar;
30(4):526-530.
PMID: 30858224
No abstract available.
9.
Black Americans' Perspectives of Barriers and Facilitators of Community Screening for Kidney Disease
Umeukeje E, Wild M, Maripuri S, Davidson T, Rutherford M, Abdel-Kader K, et al.
Clin J Am Soc Nephrol
. 2018 Mar;
13(4):551-559.
PMID: 29545381
Background And Objectives: Incidence of ESKD is three times higher in black Americans than in whites, and CKD prevalence continues to rise among black Americans. Community-based kidney disease screening may...
10.
Young B, Fullerton S, Wilson J, Cavanaugh K, Blacksher E, Spigner C, et al.
Semin Nephrol
. 2017 Nov;
37(6):552-557.
PMID: 29110763
End-stage renal disease (ESRD) disproportionately affects African Americans, who are two to four times more likely than European Americans to develop ESRD. Two independent variants of the apolipoprotein L1 (APOL1)...